Last May 3-5, 2025, Dr. Matías Fernández Viña, Medical Director and Founder of Stem Cell Therapy Argentina, participated in the prestigious Isokinetic 2025 Congress, organized in collaboration with FIFA, at the iconic Cívitas Metropolitano stadium of Atlético de Madrid, in Spain. This event, considered the most important worldwide in sports medicine, brought together the most prominent experts in the field, including the renowned Dr. Gil Rodas of FC Barcelona, with whom Dr. Fernández Viña had the opportunity to exchange knowledge and experiences.
During the congress, Dr. Fernández Viña, a pioneer in regenerative therapies with more than a decade of experience in the use of mesenchymal stem cells and hyperconcentrated platelet-rich plasma, was able to remain at the forefront of global scientific advances. His participation not only reinforces Stem Cell Therapy Argentina’s commitment to excellence, but also consolidates its position as a benchmark in regenerative medicine in Latin America.
Attendance at events of this magnitude underscores the importance for physicians to be constantly certified and updated. These opportunities allow professionals like Dr. Fernández Viña to offer their patients the most advanced and effective therapies, guaranteeing quality treatments based on the latest scientific evidence. For patients, this translates into better results, as evidenced by the testimonials of those who have recovered their quality of life thanks to Stem Cell Therapy Argentina’s non-surgical treatments.
With offices in Buenos Aires, Mendoza, Río Cuarto and soon in Tucumán, Stem Cell Therapy Argentina continues to lead the region, demonstrating that participation in international events such as the Isokinetic 2025 Congress is key to remain at the forefront and continue transforming lives through regenerative medicine.
For more information about their services and developments, visit www.stemcelltherapyargentina.com and subscribe to their newsletter.
Stem Cell Therapy Argentina is an original brand of Regenerative Medicine, being a reference in the field of mesenchymal stem cell treatments.
